Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

Published 2010 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
Authors
Keywords
-
Journal
LANCET
Volume 375, Issue 9724, Pages 1437-1446
Publisher
Elsevier BV
Online
2010-04-15
DOI
10.1016/s0140-6736(10)60172-9

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.